Investment House LLC Has $3.53 Million Holdings in Danaher Co. (NYSE:DHR)

Investment House LLC boosted its stake in shares of Danaher Co. (NYSE:DHR) by 3.3% in the 4th quarter, Holdings Channel.com reports. The firm owned 15,391 shares of the conglomerate’s stock after buying an additional 485 shares during the quarter. Investment House LLC’s holdings in Danaher were worth $3,533,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently bought and sold shares of the company. Heck Capital Advisors LLC acquired a new position in Danaher during the 4th quarter valued at $27,000. Decker Retirement Planning Inc. acquired a new position in Danaher during the 4th quarter valued at $31,000. Golden State Wealth Management LLC acquired a new position in Danaher during the 4th quarter valued at $31,000. Strategic Financial Concepts LLC acquired a new position in Danaher during the 4th quarter valued at $31,000. Finally, Pineridge Advisors LLC raised its stake in Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after purchasing an additional 57 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Up 0.1 %

Shares of NYSE:DHR opened at $212.71 on Wednesday. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70. The company’s 50-day moving average price is $219.04 and its two-hundred day moving average price is $239.67. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The firm has a market cap of $152.03 billion, a P/E ratio of 40.29, a P/E/G ratio of 2.66 and a beta of 0.82.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the company posted $2.09 EPS. As a group, research analysts forecast that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a dividend of $0.32 per share. The ex-dividend date is Friday, March 28th. This is an increase from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a yield of 0.60%. Danaher’s dividend payout ratio is presently 24.24%.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 10.90% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. Bank of America upgraded shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price for the company in a research note on Friday, December 13th. Barclays dropped their price objective on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Jefferies Financial Group dropped their price objective on shares of Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a research note on Wednesday, January 29th. The Goldman Sachs Group set a $250.00 price objective on shares of Danaher in a research note on Wednesday, January 15th. Finally, Robert W. Baird dropped their price objective on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Six research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $277.76.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.